PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
Treatment with 200 mg/d of Eriomin significantly decreased blood glucose (-5%), HOMA-IR (-11%), glucagon (-13%), IL-6 (-14%), and TNF-alpha (-20%) [PMID:35796695]
Citrus bioflavonoids may prevent the absorption of endotoxins from the gut [PMID:29908580]
Epidemiological studies associate intake of citrus flavonoid-containing foods with decreased incidence of cardiovascular disease and improved cardiovascular outcomes [PMID:27146015, PMID:30962863]
Clinical evidence regarding the effects of citrus flavonoids on managing autoimmune diseases remains controversial [PMID:35770398]
Safety & adverse effects
Drug interactions
Evidence summary
PubMed sources
- 1.PMID: 33435726 (2022) — Citrus flavonoids and their antioxidant evaluation. · Critical reviews in food science and nutrition
- 2.PMID: 37570594 (2023) — Phytochemical Properties, Extraction, and Pharmacological Benefits of Naringin: A Review. · Molecules (Basel, Switzerland)
- 3.PMID: 29908580 (2018) — Is psoriasis a bowel disease? Successful treatment with bile acids and bioflavonoids suggests it is. · Clinics in dermatology
- 4.PMID: 39898883 (2025) — Citrus Flavonoids as Antimicrobials. · Chemistry & biodiversity
- 5.PMID: 35796695 (2022) — Nutraceutical Eriocitrin (Eriomin) Reduces Hyperglycemia by Increasing Glucagon-Like Peptide 1 and Downregulates Systemic Inflammation: A Crossover-Randomized Clinical Trial.